These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hypothalamic somatostatin mediates the suppression of growth hormone secretion by centrally administered thyrotropin-releasing hormone in conscious rats. Katakami H; Arimura A; Frohman LA Endocrinology; 1985 Sep; 117(3):1139-44. PubMed ID: 2862016 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of calcitonin-induced growth hormone (GH) suppression: roles of somatostatin and GH-releasing factor. Lengyel AM; Tannenbaum GS Endocrinology; 1987 Apr; 120(4):1377-83. PubMed ID: 2881773 [TBL] [Abstract][Full Text] [Related]
4. Alpha 2-adrenergic control of growth hormone (GH) secretion in conscious male rabbits: involvement of endogenous GH-releasing factor and somatostatin. Minamitani N; Chihara K; Kaji H; Kodama H; Kita T; Fujita T Endocrinology; 1989 Dec; 125(6):2839-45. PubMed ID: 2479528 [TBL] [Abstract][Full Text] [Related]
5. Plasma growth hormone (GH) response to intravenous GH-releasing factor (GRF) in adult rats: evidence for transient pituitary desensitization after GRF stimulation. Arsenijevic Y; Rivest RW; Eshkol A; Sizonenko PC; Aubert ML Endocrinology; 1987 Oct; 121(4):1487-96. PubMed ID: 2888646 [TBL] [Abstract][Full Text] [Related]
6. Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist. Lumpkin MD; McDonald JK Endocrinology; 1989 Mar; 124(3):1522-31. PubMed ID: 2537185 [TBL] [Abstract][Full Text] [Related]
7. Effects of intraventricular growth hormone-releasing factor on growth hormone release: further evidence for ultrashort loop feedback. Lumpkin MD; Samson WK; McCann SM Endocrinology; 1985 May; 116(5):2070-4. PubMed ID: 3921349 [TBL] [Abstract][Full Text] [Related]
8. Time-dependent reduction and potentiation of growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous GH: role for somatostatin. Lanzi R; Tannenbaum GS Endocrinology; 1992 Apr; 130(4):1822-8. PubMed ID: 1347739 [TBL] [Abstract][Full Text] [Related]
9. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion. Vance ML; Kaiser DL; Evans WS; Furlanetto R; Vale W; Rivier J; Thorner MO J Clin Invest; 1985 May; 75(5):1584-90. PubMed ID: 2860126 [TBL] [Abstract][Full Text] [Related]
10. Combined effects of human growth hormone (GH)-releasing factor-44 (GRF) and somatostatin (SRIF) on post-SRIF rebound release of GH and prolactin: a model for GRF-SRIF modulation of secretion. Stachura ME; Tyler JM; Farmer PK Endocrinology; 1988 Sep; 123(3):1476-82. PubMed ID: 2900135 [TBL] [Abstract][Full Text] [Related]
11. Effects of intracellular glucopenia on pulsatile growth hormone secretion: mediation in part by somatostatin. Painson JC; Tannenbaum GS Endocrinology; 1985 Sep; 117(3):1132-8. PubMed ID: 2862015 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of pulsatile growth hormone (GH) secretion and somatic growth in immature rats with a synthetic GH-releasing factor antagonist. Lumpkin MD; Mulroney SE; Haramati A Endocrinology; 1989 Mar; 124(3):1154-9. PubMed ID: 2492921 [TBL] [Abstract][Full Text] [Related]
13. Sexual dimorphism of somatostatin and growth hormone-releasing factor signaling in the control of pulsatile growth hormone secretion in the rat. Painson JC; Tannenbaum GS Endocrinology; 1991 Jun; 128(6):2858-66. PubMed ID: 1674685 [TBL] [Abstract][Full Text] [Related]
14. Involvement of hypothalamic growth hormone (GH)-releasing factor in GH secretion induced by intracerebroventricular injection of somatostatin in rats. Murakami Y; Kato Y; Kabayama Y; Inoue T; Koshiyama H; Imura H Endocrinology; 1987 Jan; 120(1):311-6. PubMed ID: 2877864 [TBL] [Abstract][Full Text] [Related]
15. Human pancreatic growth hormone-releasing factor stimulates release of growth hormone in conscious unrestrained male rabbits. Chihara K; Minamitani N; Kaji H; Kodama H; Kita T; Fujita T Endocrinology; 1983 Dec; 113(6):2081-5. PubMed ID: 6139274 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of hypothalamic medial preoptic area somatostatin on growth hormone-releasing factor in the rat. Katakami H; Downs TR; Frohman LA Endocrinology; 1988 Aug; 123(2):1103-9. PubMed ID: 2899498 [TBL] [Abstract][Full Text] [Related]
17. Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid. Chihara K; Kashio Y; Abe H; Minamitani N; Kaji H; Kita T; Fujita T J Clin Endocrinol Metab; 1985 Feb; 60(2):269-78. PubMed ID: 3917456 [TBL] [Abstract][Full Text] [Related]
18. Somatostatin rapidly restores rat growth hormone (GH) release response attenuated by prior exposure to human GH-releasing factor in vitro. Soya H; Suzuki M Endocrinology; 1988 Jun; 122(6):2492-8. PubMed ID: 2897284 [TBL] [Abstract][Full Text] [Related]
19. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor. Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164 [TBL] [Abstract][Full Text] [Related]
20. Synergistic interaction between insulin-like growth factors-I and -II in central regulation of pulsatile growth hormone secretion. Harel Z; Tannenbaum GS Endocrinology; 1992 Aug; 131(2):758-64. PubMed ID: 1639021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]